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Poisons of caterpillars have different effects on inﬂammatory and coagulation systems.
This is a case report of a 2-year-old child that accidentally came in contact with several
caterpillars of the species Lonomia obliqua.  At ﬁrst, the patient’s exams presented abnormal
coagulation and decreased ﬁbrinogen, but the patient did not evolve to active bleeding or
acute  renal failure. The patient received antilonomic serum 15 h after the accident and the
treatment was repeated after another 12 h due to persistent alterations shown by the coag-
ulation exams. The venom of L. obliqua has several substances that act on the coagulation
and  inﬂammatory systems. The event is characterized by a hemorrhagic syndrome with
decreases in ﬁbrinogen. L. obliqua Stuart-factor activator (Losac) and L. obliqua prothrombin
activator protease (Lopap) are components that act with procoagulatory effects. The pro-
inﬂammatory action occurs due to metalloproteases, hyaluronidases and other substances
with  inﬂammatory activity. Studies on caterpillar venom can give new perspectives on the
treatment of cancer and other diseases that cause dysfunction of the extra-cellular matrix.©  2014 Associac¸ão Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published
by Elsevier Editora Ltda. All rights reserved.
quently on the upper limbs of children and rural workers.ntroduction
aterpillars are the larval stage of butterﬂies and moths.
ontact with the bristles of some caterpillars induce varied
1ymptoms from mild discomfort to systemic bleeding.
The earliest records of accidents involving lepidopteran
aterpillars in Brazil were described by Zoroastro Alvarenga
∗ Corresponding author at: Hospital Israelita Albert Einstein, Av. Albert 
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ttp://dx.doi.org/10.1016/j.bjhh.2014.07.021
516-8484/© 2014 Associac¸ão Brasileira de Hematologia, Hemoterapia
eserved.in 1912, but it was only in 1967 that studies on this insect were
intensiﬁed.1 Between 1989 and 2001, 5673 accidents and 21
deaths occurred in the south of Brazil.2
Accidents with Lonomia obliqua (Figure 1) occur most fre-
1Einstein, 627, Morumbi, 05652-900 São Paulo, SP, Brazil.
There is a seasonal distribution of accidents involving this
caterpillar, with increased numbers of cases in spring and
summer, the period that corresponds to the caterpillar stage.1
 e Terapia Celular. Published by Elsevier Editora Ltda. All rights
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IV, followed by 15 mg/kg every 4 h until coagulation isFigure 1 – Lonomia obliqua.
L. obliqua releases toxins with anticoagulant properties
through its bristles. These toxins in contact with the skin can
cause pain, redness, swelling and a burning sensation at the
site, and headache, nausea, vomiting, hematoma, hematuria,
bruising, anemia and leucocitosis.2
The clotting time increases, coagulation factors levels
decrease and ﬁbrin degradation products increase after
accidents with L. obliqua. The difference between L. obli-
qua poisoning and other coagulopathies is the absence of
thrombocytopenia.1
Case  report
This is the case of JNF, a Caucasian infant boy of 2 years and 2
months, born and living in the city of São Paulo, Brazil.
The patient was brought to the emergency department
with a history of an accident involving contact with caterpil-
lars 10 h previously. The patient had been on his father’s lap
in the garden at home when he touched the trunk of a tree
and felt an intense burning pain in the palm of his hand. At
this time, the father noticed that the child had touched a clus-
ter of caterpillars. These caterpillars were described as being
more or less 5 cm in length and covered with bristles, with a
light brown/green color. The patient had a past medical history
of respiratory atopy and regularly took montelukast, but with
no other relevant family medical history. He was in a regu-
lar medical condition, eupneic, hydrated, acyanotic, anicteric,
afebrile and active. His heart rate was 67 beats per minute, the
respiratory rate was 20 breaths per minute, and blood pressure
97 × 47 mmHg. His weight was 14 kg, height 86 cm,  and oxy-
gen saturation was 97% in normal atmosphere. The physical
examination was normal, except for micropapules on the left
hand. No hematomas or petechiae were evidenced.
The patient was admitted to the intensive care unit. The
accident was rated as moderately severe because of the alter-
ations in clotting assays despite the lack of hemorrhagic
manifestations. Fifteen hours after the accident, the patient
received three ampules of antilonomic serum. Before the
infusions, he received 10 mg/kg of hydrocortisone and 1 mg/kg
of diphenidramin. Twelve hours after the ﬁrst administra- 2 0 1 4;3  6(6):445–447
tion of antilonomic serum, he received two more  ampoules,
because the coagulation tests were still abnormal. The patient
evolved well, without bleeding, hematoma or hematuria, with
good urinary excretion and without renal alterations. He was
discharged with normal laboratory exams (Table 1).
Discussion
The patient described in this report presented with prolonged
coagulation times including prothrombin time and activated
partial thromboplastin time as well as hypoﬁbrinogenemia,
which improved after the infusion of antilonomic serum. He
did not present thrombocytopenia during hospitalization.
In accidents involving L. obliqua poisoning, the most severe
manifestations are renal failure and intracerebral hemor-
rhage; this patient evolved with neither of these signs. The
pathophysiology of these alterations is poorly understood.
Intracerebral hemorrhage is the main cause of death.3 In the
state of Paraná in the south of Brazil, hemorrhage was present
in 50% of the patients suffering accidents involving L. obli-
qua. Hematuria is frequently observed and some histological
reports show acute tubular necrosis.3
The venom of L. obliqua has several substances that act
on the coagulation and inﬂammatory systems. The event is
characterized by a hemorrhagic syndrome with a decrease in
ﬁbrinogen; decreases in ﬁbrinogen and thrombocytopenia are
severity markers.3
In the coagulation system, Losac and Lopap have procoag-
ulatory effects with Losac being described ﬁrst. The enzyme
activates factor X at levels that depend on the concentration of
venom and the FXa complex formed integrates the prothrom-
binase complex. Blood and kidney venom levels are high 1 h
after contact, but the venom is completely eliminated within
24 h, suggesting that the endothelium and coagulation fac-
tors are the venom’s most likely targets.4 Lopap is a protease
with linear kinetics that activates prothrombin without form-
ing the prothrombinase complex; its activity is inhibited by
the antilonomic serum.5,6
The pro-inﬂammatory action occurs due to metallopro-
teases, hyaluronidases and other substances with inﬂamma-
tory activity.7 Injecting L. obliqua venom in rats increased the
expression of endothelial E-selectin, and vascular cell adhe-
sion protein 1 and caused the activation of leukocyte, and
the induction of necrosis factor kappa-, cyclooxygenase-2,
heme oxygenase-1and inducible nitric oxide synthase.8 Lopap
and Losac also play a role in the up-regulation of the expres-
sion of pro-inﬂammatory molecules such as interleukin 8, and
intercellular adhesion molecule-1.4
Treatment consists in the injection of antilonomic serum
which was developed in Brazil in 1996 by obtaining antibodies
extracted from horses immunized with extracts from the bris-
tles of caterpillars. This serum contains the F(ab’) fragment of
G immunoglobulin.9
Another antiﬁbrinolytic agent that can be used is epsilon
aminocaproic acid (EACA) at an initial dosage of 30 mg/kgnormalized.10 This was the recommended treatment prior to
the development of the antilonomic serum, based on the treat-
ment results of other types of lonomia sp. Envenomation.3
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Table 1 – Laboratory exams.
8 h after accident 27 h after accident 35 h after accident At discharge
Prothrombin time (s) >120.0 160.0 16.3 12.3
INR 12.8 10.0 1.34 1.0
APTT (s) 123 37.9 27.0 27.0
APTT ratio 3.71 1.32 0.9 0.9
Fibrinogen (mg/dL) – 35 87 115
Hemoglobin (g/dL) – 9.1 10.8 11.6
Hematocrit (%) – 28.0 32.4 35.5
Leukocytes (×103/uL) – 7.8 6.3 11.4
Platelets (×103/uL) – 237 264 352
Urea (mg/dL) – 15 17 28
Creatinine (mg/dL) – 0.3 0.3 0.3
Sodium (mEq/L) – 127 139 –
Potassium (mEq/L) 5.9 4.5 –
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10. Fundac¸ão Nacional de Saúde. Manual de Diagnóstico eINR: international normalized ratio; APTT: activated partial thrombo
xperimental studies did not demonstrate a normalization of
brinogen and clotting factors 1 and 6 h after the infusion of
ACA, respectively.3
The understanding of the components and the action of
he venom may be useful in treating diseases and developing
rugs. Lopap is rich in lipocalin, a protein involved in cellu-
ar regeneration and remodeling and in control of apoptosis.
he study of this substance may help in the treatment of
iseases in which there is dysfunction of the extra-cellular
atrix, such as diabetes, renal failure, and pulmonary and
eart diseases.1,3 Lopap was also studied in rats in order to
everse the anticoagulant effect of low molecular weight hep-
rin. The outcome is interesting as protamin, the antidote
urrently available, reverses only 60% of the effect caused by
ow molecular weight heparin.8
This report emphasizes the importance of knowing the
emorrhagic and inﬂammatory effects of L. obliqua venom,
s well as its treatment. Studying the substances involved
nables the development of new treatments for current dis-
ases.
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